JG
ADMS

Jefferies Group’s Adamas Pharmaceuticals ADMS Stock Holding History

Jefferies Group’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,135
Closed -$107K – 2848
2019
Q4 		$107K Buy
28,135
+877
+3% +$4.2K ﹤0.01% 2375
2019
Q3 		$139K Buy
+27,258
New +$168K ﹤0.01% 2451
2019
Q2 		– Sell
-15,000
Closed -$107K – 3003
2019
Q1 		$107K Buy
+15,000
New +$135K ﹤0.01% 2103
2015
Q3 		– Sell
-87
Closed -$2K – 3303
2015
Q2 		$2K Buy
+87
New +$1.69K ﹤0.01% 3161

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's ADMS Position: Q1 2020 in Review

Jefferies Group sold out of Adamas Pharmaceuticals (ADMS) in Q1 2020, closing a stake of 28,135 shares — an estimated $107K sold.

Jefferies Group first reported a position in ADMS in Q2 2015 and held it in 4 quarters. The position peaked at $139K in Q3 2019. 73 funds tracked by Wall St. Rank hold ADMS as of Q1 2020.

  • Jefferies Group reported no remaining Adamas Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 28,135 Adamas Pharmaceuticals shares in Q1 2020, an estimated $107K.
  • Jefferies Group first reported a position in Adamas Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Jefferies Group's Adamas Pharmaceuticals position peaked at $139K in Q3 2019.
  • 73 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.